IP Library › Granted Patent US 11,389,386
Granted Patent B2
US 11,389,386 · App. 16/074,043 · Granted Jul 19, 2022

Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens

Inventors: Douglas A. Loy (Tucson, AZ); Stephanie H. Tolbert (Tucson, AZ)
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
A61K8/585A61K8/025A61Q17/04C01B33/12C01B33/18A61K2800/412A61K2800/413A61K2800/43A61K2800/95C01P2002/84C01P2002/85C01P2004/03C01P2004/04C01P2004/32C01P2004/51C01P2004/52C09C1/3063
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,389,386
App. No.
16/074,043
Granted
Jul 19, 2022
Kind
B2
Abstract

Bridged polysilsesquioxane based sunscreens prepared as nanoparticles via oil/water microemulsion polymerization, sol-gel polymerizations, or a modified Stober process. Minimized leaching and decreased levels of photo-degradation were achieved with covalent incorporation, with bridged incorporation necessary to ensure isolation of the sunscreen and any photo-products from skin. SPF values of were found to be comparable to existing commercial sunscreens. Furthermore the bridged polysilsesquioxane based sunscreens can be classified as broad-spectrum, and rate from moderate to superior in terms of UVA protective ability.

Claims (22)

1. A sunscreen composition comprising one or more monomers of a bridged compound according to Formula I:

wherein A is a UV absorbing moiety, wherein A is selected from a group consisting of salicylate, curcuminoid, benzophenone, acetophenone, and cinnamate monomers,

wherein L 1 is a linker group according to Formula II, III, or IV:

wherein B is a trialkoxysilyl group,

wherein n is at least 2,

wherein L 1 is covalently bonded to A to effectively prevent leeching of A from the sunscreen composition, wherein the multiple trialkoxysilyl groups of the bridged compound monomers are polymerized with tetraalkoxysilane comonomers to form bridged polysilsesquioxane-based sunscreen particles, and wherein the sunscreen composition is resistant to photo-degradation.

2. The sunscreen composition of claim 1 , wherein A comprises at least two functional groups selected from a group consisting of a hydroxyl, an amine, and a carboxylic acid moiety, wherein L 1 is covalently bonded to the functional group.

3. The sunscreen composition according to claim 1 , wherein the trialkoxysilyl group is a triethoxysilyl group or trimethoxysilyl group.

4. The sunscreen composition according to claim 1 , further comprising silicate comonomers in concentrations ranging from 0.001-95 mole %, wherein the silicate comonomers are copolymerized with the bridged compound monomers to form the bridged polysilsesquioxane-based sunscreen particles.

5. The sunscreen composition of claim 4 , wherein the silicate comonomers are selected from a group consisting of tetraalkoxysilane comonomers, sodium silicate comonomers, and organotrialkoxysilane comonomers.

6. The sunscreen composition of claim 5 , wherein the tetraalkoxysilane comonomers are selected from a group consisting of tetramethoxysilane comonomers and tetraethoxysilane comonomers.

7. The sunscreen composition according to claim 1 , wherein each sunscreen particle has a mean diameter of about 50 to 750 nm.

8. The sunscreen composition according to claim 1 , wherein the sunscreen composition is prepared by sol gel polymerization, microemulsion polymerization, or modified Stober polymerization.

9. A sunscreen formulation comprising:

a. the sunscreen composition according to claim 1 , wherein the sunscreen composition is present in an amount effective to absorb UV radiation; and

b. a pharmaceutically-acceptable sunscreen carrier.

10. A sunscreen composition comprising one or more monomers of a bridged compound according to Formula I:

wherein A is a UV absorbing moiety, wherein A is selected from a group consisting of salicylate; curcuminoid, benzophenone, acetophenone, and cinnamate monomers,

wherein L 1 is a linker group according to Formula II, III, or IV:

wherein B is a trialkoxysilyl group,

wherein n is at least 2,

wherein L 1 is covalently bonded to A to effectively prevent leeching of A from the sunscreen composition, wherein the multiple trialkoxysilyl groups of the bridged compound monomers are reacted with tetrafunctional comonomers to form bridged polysilsesquioxane-based sunscreen particles, and wherein the sunscreen composition is resistant to photo-degradation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2018
From: LOY, DOUGLAS A.; TOLBERT, STEPHANIE H.
To: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
Reel/Frame 046538/0566 →
Continuity (2)
Provisional Application 62288795 · Jan 29, 2016
Related Publication 20190038537A1 · Feb 7, 2019